• FDA approves Nerlynx for adjuvant treatment of HER-2-positive breast cancer

    3 days ago - By Healio

    The FDA today approved neratinib for extended adjuvant treatment of adults with early-stage HER-2-positive breast cancer who completed adjuvant trastuzumab-based therapy.Neratinib is an oral, irreversible tyrosine kinase inhibitor.
    Read more ...

     

  • Study finds low rate of breast cancer recurrence after nipple-sparing mastectomy

    3 days ago - By News Medical

    Women with breast cancer who undergo nipple-sparing mastectomy have a low rate of cancer returning within the first five years when most recurrences in the breast are diagnosed, findings of a single-center study show.
    Read more ...

     

  • Radiation Before Surgery In Breast Cancer Patients Lowers Risk of Secondary Tumors

    Radiation Before Surgery In Breast Cancer Patients Lowers Risk of Secondary Tumors

    3 days ago - By Medindia Health

    Radiation therapy decreases the size of the tumor before surgery in patients with breast cancer. The study analyzed the long-term effects of neoadjuvant radiation therapy on breast cancer patients.
    Read more ...

     

  • FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

    3 days ago - By News Medical

    The U.S. Food and Drug Administration today approved Nerlynx for the extended adjuvant treatment of early-stage, HER2-positive breast cancer.
    Read more ...